Hyperkalaemia

13 registered clinical trials studyying Hyperkalaemia — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	AI-Enabled ECG Stratification and Timing of Potassium-Lowering Therapy in Patients With Hyperkalemia: A Target NCT07307729	National Defense Medical Center, Taiwan	N/A
Recruiting	Patiromer and Diet/hrQoL in Chronic Dialysis NCT06858280	Mario Negri Institute for Pharmacological Research	Phase 3
Completed	VITALIZE.Use and Effectiveness of Sodium Zirconium Cyclosilicate (LokelmaTM) in the Real-world Setting in Spai NCT06635499	AstraZeneca	—
Completed	A National, Multicenter, Prospective, Observational Study to Assess Patient Characteristics, Treatment Algorit NCT06185660	AstraZeneca	—
Completed	Safety of Oral Resin for Treatment of Hyperkalemia in Chinese Patients With Renal Insufficiency NCT05462119	AstraZeneca	—
Completed	Continuing Sodium Zirconium Cyclosilicate (SZC) After Discharge Study NCT05347693	AstraZeneca	Phase 4
Completed	A Multicenter, Prospective, Non-interventional Cohort Study to Evaluate the Safety and Treatment Pattern of So NCT05271266	AstraZeneca	—
Terminated	Study of SZC and Enhanced Nutrition Advice Compared to SoC in Dialysis Patients With Hyperkalaemia NCT04997161	AstraZeneca	Phase 4
Completed	Hyperkalaemia and Its Impact on Therapy with RAASi NCT04249648	Portsmouth Hospitals NHS Trust	—
Completed	Study to Assess the Effect of Sodium Zirconium Cyclosilicate on the Pharmacokinetics of Tacrolimus and Cyclosp NCT04788641	AstraZeneca	Phase 1
Terminated	Study of the Effect of SZC on Serum Potassium and Serum Bicarbonate in Patients With Hyperkalemia and Metaboli NCT04727528	AstraZeneca	Phase 3
Completed	Study to Assess Efficacy and Safety of SZC for the Management of High Potassium in Patients With Symptomatic H NCT04676646	AstraZeneca	Phase 4
Recruiting	An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia NCT03813407	AstraZeneca	Phase 3